Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway
Xiangnan Zhou,1,2,* Xiuhua Hu,2,3,* Zhiying Zhang,2,* Shicheng Lin,2 Ximing Lin,2 Tian Zhou,2 Yanping Bai,1 Kaiwen Hu2 1Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrated Traditional Chinese and Western Medicine, Beijing, 10...
Saved in:
| Main Authors: | Zhou X, Hu X, Zhang Z, Lin S, Lin X, Zhou T, Bai Y, Hu K |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/xingxiao-pill-suppressed-the-progression-of-non-small-cell-lung-cancer-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axis
by: Jingjing Zhang, et al.
Published: (2025-04-01) -
Zuogui Pill Promotes Neurovascular Regeneration and Corticospinal Tract Remodeling After Ischemic Stroke
by: Wu D, et al.
Published: (2025-05-01) -
Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway
by: Saiji Liu, et al.
Published: (2024-11-01) -
Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer
by: Jiannan Chen, et al.
Published: (2025-07-01) -
Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01)